If the LOI becomes a binding contract, Pure Extracts will contribute “a mix of equipment and cash to the venture”, which will allow the partners to rapidly scale-up to…
psychedelics
Lobe Sciences (LOBE.C) joined the NFL Alumni Association (NFLAA) as an enterprise member today, according to a press release. Enterprise membership in the NFL Alumni Association gives Lobe the…
Cybin’s (CYBN.NE) subsidiary Adelia Therapeutics completed earnout milestones originally set in a contribution agreement for the period of January 1, 2021, following Cybin’s acquisition of Adelia. There are a…
Graph Blockchain (GBLC.C) appointed Paul Faber, a director of the company, to the position of chief executive officer on Friday, and by Monday he’d started with a bang by…
At a time when many cannabis companies are enjoying bursts of investor interest, management at BC-based extractor Pure Extracts (PULL.C) must be getting frustrated as they roll out new…
Delic Holdings (DELC.C) agreed to acquire the Homestead brand and its intellectual property today. Homestead is a psychedelic counterculture media operation, and a creator of one of the first…
Mind Cure Health (MCUR.C) started their first stage of manufacturing pharma-grade ibogaine for both preclinical and clinical research today, according to a press release. Ibogaine is a psychoactive compound…
For a year, naysayers have dismissed the early stage shroom boom as being a pumpy bunch of pubco RTOs that won’t be able to do business legally for years….
PULL submitted over 20 Stock Keeping Units (SKU) product identifiers for approval including THC vapes, CBD vapes, 1:1 blended vapes, and 3 different flavours/formulations of gummies….
Mydecine Innovations Group (MYCO.C) expanded their relationship with Applied Pharmaceutical Innovation (API) to include the University of Alberta in support of multiple drug development and clinical trials, according to…